Atai

Biopharmaceutical company accelerating the development of mental health treatments

placeMunich, Bavaria, Germany calendar_todayFounded 2018 groups119 employees language atai.life

Social engagement

Social engagement: 34K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

63 investors on record.

Investor typeCountShare
Angel & family office1117%
Other / undisclosed5283%

Recent activity

25 Jun 2026
Milestone
U.S.
15 Jun 2026
Event
H.C. Wainwright & Co., LLC Neuro Perspectives Conference and UBS Virtual CNS Day
4 Jun 2026
Event
From patients to partners: Early insights from a patient-led care model following psychedelic treatment
Coming soon